Is it Time to Characterize COVID-19 mRNA Vaccine as Pharmaceutical Drugs, NOT Vaccines - Oct 2022


Is it Time to Characterize COVID-19 mRNA Vaccine as Pharmaceutical Drugs & NOT Vaccines?

Trial Site News Oct 15, 2022

  • "Why? The Italian authors argue that the COVID-19 mRNA vaccines do not contain antigens but rather an active SARS-CoV-2 S protein mRNA, representing both an active principle and a prodrug. "

  • The spike hypothesis in vaccine-induced adverse effects: questions and answers - Oct 2022 doi: 10.1016/j.molmed.2022.07.009. FREE PDF


1061 visitors, last modified 16 Oct, 2022,
Printer Friendly Follow this page for updates